Form EFFECT Aspire Biopharma Holding
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 29, 2025 9:00 A.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Superior Shower Doors Debuts High-End Frameless Installations in Bergen County
- Bitcoin Price Prediction After the $80,400 Bounce: Why Remittix Could Be the Surprise Winner of Q4
- Ethereum Price Prediction: Can ETH Return to $3,000 Before Remittix Completes Its Final Price Climb?
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share